Recommendations for management of diabetes during Ramadan: update 2010. - Wikidata - awgldk - TriplyDB

Recommendations for management of diabetes during Ramadan: update 2010.

Recommendations for management of diabetes during Ramadan: update 2010.

http://www.wikidata.org/entity/Q34016169

about

Options for Controlling Type 2 Diabetes during Ramadan Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial Evidence Is Ramadan fasting related to health outcomes? A review on the related evidence The effects of intermittent fasting during the month of Ramadan in chronic haemodialysis patients in a tropical climate country Intervention for Diabetes with Education, Advancement and Support (IDEAS) study: protocol for a cluster randomised controlled trial.Health education to diabetic patients before the start of Ramadan: Experience from a teaching hospital in Dammam Knowledge of diabetes mellitus and safe practices during Ramadan fasting among Muslim patients with diabetes mellitus in Singapore.A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study.Flash glucose monitoring system may benefit children and adolescents with type 1 diabetes during fasting at Ramadan.Diet restriction in Ramadan and the effect of fasting on glucose levels in pregnancy.Predetermined Anti-Diabetic Drug Regimen Adjustments during Ramadan Fasting: An Observational Study of Safety.Fasting during the month of Ramadan among patients with chronic kidney disease: renal and cardiovascular outcomes.The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study.Evaluating the Effect of Ramadan Fasting on Muslim Patients with Diabetes in relation to Use of Medication and Lifestyle Patterns: A Prospective Study Diabetes patient management by pharmacists during Ramadan Islamic fasting and multiple sclerosis.Ramadan and diabetes: As-Saum (The fasting).The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial.Impact of an individualized type 2 diabetes education program on clinical outcomes during Ramadan Recommendations for management of diabetes during Ramadan: update 2015.Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan.Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan.Fasting guidelines for diabetic children and adolescents.Need for Ramadan guidelines in various aspects of health.Glycemic Control among Pregnant Diabetic Women on Insulin Who Fasted During Ramadan.Metabolic parameters in type 2 diabetic patients with varying degrees of glycemic control during Ramadan: An observational study.Risk factors on hypertensive disorders among Jordanian pregnant women.Comparison of National/Regional Diabetes Guidelines for the Management of Blood Glucose Control in non-Western Countries Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study.Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study Diabetes mellitus and Ramadan in Algeria.Having diabetes and having to fast: a qualitative study of British Muslims with diabetes Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA-Ramadan): a randomized trial.Vildagliptin vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study.Pragmatic dietary advice for diabetes during Navratris.Implementation of Ramadan-specific diabetes management recommendations: a multi-centered prospective study from Pakistan.The diabetic patient in Ramadan.Fasting, Diabetes, and Optimizing Health Outcomes for Ramadan Observers: A Literature Review.

P2860

Q26752613-2B4F98DB-967B-456D-BF7E-A590A06A0F3E Q26752669-D3A7064A-2C45-4128-90C2-8F4E28B8C04B Q26996704-C6FA8DB1-2F53-441A-BAA0-D3A9F5FB5F52 Q28542894-CCD544EC-AC7C-44DB-B3F9-C3939CED4494 Q30393555-6277C1D2-8AC6-4038-8E7B-DB1F75059D5E Q33660808-F17D49E5-709C-49AE-980F-4FFDE6D8B504 Q33701195-27ED9FAE-8981-488B-BA71-CCB57A6B62DC Q33710159-348A6B55-7EE5-477A-8955-0384BC03DB38 Q33735226-240D13D4-387D-4DB3-9DED-B26C074E7D44 Q33869779-1661B1C3-D949-4AC3-B7BC-229F2B291F2D Q33889887-8ECF7132-99C4-44F2-A3AC-445ED6749967 Q34400647-2F9B6715-C186-406C-B3D0-16E6D6A6FDB9 Q34502809-55E09E9B-D4FE-4B19-8520-CF4F7BA48070 Q34574328-60BBA948-5017-49C8-91F7-B6A539143C16 Q35114116-D58B4570-9535-4E1B-A634-58761370BA26 Q35127335-43E6ECED-2FF3-4D6D-B446-D71301BC77EF Q35352472-86D8E983-7BDE-4237-8C75-644C36C9DE72 Q35659489-D74039F1-2B20-47B1-A1E1-E536C14378E2 Q35768892-2C95A5C0-2799-49ED-95E7-8CA22E0C0748 Q35768907-57EDA47A-8543-4D8C-B8E4-EA2EA914C2D6 Q35997284-AF27E489-DDDB-46F6-BFC5-350CE6D1DA32 Q36107741-FBBF6BA3-BB81-40DD-8F07-EFC4716834E3 Q36107755-A6972F50-3A18-47A7-9DEF-16FFCA738982 Q36107849-AA9AB14D-0C8D-43F4-BE05-2B084B065D37 Q36314259-9154737E-FFF2-4925-A2D6-2FB1FD798FA2 Q36477659-855024E4-4082-4246-A09D-7D12A0B9D857 Q36780030-452A01DA-CC9F-40C7-901B-D8EE64B60098 Q36941705-E6BD014C-1371-41C6-A68A-C467AE89AD04 Q37142980-04046834-70C1-4810-BB4D-0BD2094D0A02 Q37239317-EAF35FDA-54D0-46AF-B9A6-8E743442DB07 Q37314670-35A8FA5A-1472-4D84-93D3-0C21F33E1919 Q37333536-D9F7532E-CF8A-4F0E-AEB0-0C87A2130C9D Q37394223-8E20C6AA-B3B5-4439-BA60-AFA1B3E82FB9 Q37417767-85D30C34-1AB7-4827-AF82-F007BD3981D5 Q37427512-CBAD3282-C013-48CD-836F-AA02F908B791 Q37468458-7105851A-E475-4DD9-9D36-F73AB0571881 Q37588849-BC88E90A-DE1F-46FB-82E1-248A3B9448B1 Q37609285-A0278758-D8D4-4FF2-97F4-0F028DB49AF8 Q37715182-A3D00F6F-C810-40D8-8D55-FA619BA293C0 Q37737460-2B144013-F291-43EB-88B4-76691D3EBA57

P2860

Recommendations for management of diabetes during Ramadan: update 2010.

http://www.wikidata.org/entity/Q34016169

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Recommendations for management of diabetes during Ramadan: update 2010.

@ast

Recommendations for management of diabetes during Ramadan: update 2010.

@en

Recommendations for management of diabetes during Ramadan: update 2010.

@nl

type

label

Recommendations for management of diabetes during Ramadan: update 2010.

@ast

Recommendations for management of diabetes during Ramadan: update 2010.

@en

Recommendations for management of diabetes during Ramadan: update 2010.

@nl

prefLabel

Recommendations for management of diabetes during Ramadan: update 2010.

@ast

Recommendations for management of diabetes during Ramadan: update 2010.

@en

Recommendations for management of diabetes during Ramadan: update 2010.

@nl

P1433

Q34016169-35EFB61A-0304-4104-A35B-16164080B350

P1476

Q34016169-BCF00E2D-4AEA-4402-B406-7C2AB74D33BD

P2093

Q34016169-06CC31D7-2D0A-4200-B5CA-9D1E83DC12B4

Q34016169-1397A5E9-E999-4AAD-B1E4-71763E3865C0

Q34016169-36B4346C-F693-4848-AD91-3BF5713CA848

Q34016169-3E033F02-653F-4B15-B182-768BC4BA8AA9

Q34016169-471C3E7E-6AC7-4C5C-BF42-BEDE66D8419A

Q34016169-775E057F-2EDC-42EB-956C-688FB6E7DD3E

Q34016169-8C81146F-BE1B-4380-B4E5-A3D70380BE98

Q34016169-8C968E3F-E52F-49D4-87B8-8CBD21ABADB3

Q34016169-90C2A253-1B6E-4A8D-B12A-ACF44343C4E0

Q34016169-911F3BC4-1F6A-42B1-AAC2-766695CE0B99

P2860

Q34016169-053FDCE8-93C9-431F-A30C-D5CDF8D02156

Q34016169-29B9EA64-FC5B-4A74-8371-30B83F8D90B8

Q34016169-2A620B1B-B0BE-4A52-8630-10D7C09C4C15

Q34016169-3742E984-4D9A-4479-BFFB-E86EA98142BB

Q34016169-3D1BCE88-AA95-4BA2-AA49-3CD3ED6CDF91

Q34016169-4657230D-7C3B-44ED-B182-DAA089F83BD7

Q34016169-4CD1EA9D-E2FA-4996-928D-E605441E589A

Q34016169-4DF076FD-EF8C-4631-84BD-FFBB64215251

Q34016169-54845078-5ED6-446E-BEE5-7B08B81485FD

Q34016169-6D7BCAB0-E2C5-4441-8852-F2A9DBD9E767

P304

Q34016169-07FEF550-4647-4DA9-847A-317EE19769E3

P31

Q34016169-6D0793A7-8291-4ED5-AB60-1F69B8EDF35B

P356

Q34016169-2F6E1AF3-48D4-4856-98C7-C188F0BD219E

P407

Q34016169-FCD95954-DD0B-48D5-9FAA-029610A20D7C

P433

Q34016169-EFD553B8-2C68-4F1B-82AA-3F3F7A1B7604

P478

Q34016169-5CBC93E7-334C-42F7-83A7-614F90B6498F

P50

Q34016169-7C3A196A-0F8F-454F-96F4-69EA1466D04F

P577

Q34016169-8D6C340C-5754-46F7-87B7-D6FD1B2296B2

P5875

Q34016169-2ED8AFFA-AF2B-40D2-A073-B3D91A1A59D9

P698

Q34016169-CBC6EF8E-9EDA-4157-88A5-52269599574D

P932

Q34016169-5B2B0F28-1C41-44CA-BD31-B3316D6C34D6

P356

P1433

P1476

Recommendations for management of diabetes during Ramadan: update 2010.

@en

P2093

Abdullah Ben Nakhi

http://www.w3.org/2001/XMLSchema#string

Abdulrazzaq Al-Madani

http://www.w3.org/2001/XMLSchema#string

Abraham Thomas

http://www.w3.org/2001/XMLSchema#string

David Kendall

http://www.w3.org/2001/XMLSchema#string

Ibtihal Fahdil

http://www.w3.org/2001/XMLSchema#string

Khaled Tayeb

http://www.w3.org/2001/XMLSchema#string

Mahmoud Ashraf Ibrahim

http://www.w3.org/2001/XMLSchema#string

Mohamed Fahmy

http://www.w3.org/2001/XMLSchema#string

Mohamed Hassanein

http://www.w3.org/2001/XMLSchema#string

Monira Al-Arouj

http://www.w3.org/2001/XMLSchema#string

P2860

Alpha-glucosidase inhibitors for type 2 diabetes mellitus

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Starvation in man

GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits.

The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus.

Alternate-day fasting and chronic disease prevention: a review of human and animal trials.

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

P304

1895-1902

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC10-0896

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45406529

http://www.w3.org/2001/XMLSchema#string

P698

20668157

http://www.w3.org/2001/XMLSchema#string

P932

2909082

http://www.w3.org/2001/XMLSchema#string